Veronica Holloway
Psychiatric/Mental Health · Des Moines, IANPI 1710549894
Payments from drug & device makers
Across 213 payments — averaging $18.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$864
- Vanda Pharmaceuticals Inc.$647
- Alkermes, Inc.$616
- Otsuka America Pharmaceutical, Inc.$522
- AbbVie$439
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$352
- plus $503 from 8 others
What the payments were for
- Food & beverage$3,931100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 45 | $864 |
| Vanda Pharmaceuticals Inc. | 27 | $647 |
| Alkermes, Inc. | 36 | $616 |
| Otsuka America Pharmaceutical, Inc. | 30 | $522 |
| AbbVie | 29 | $439 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 18 | $352 |
| Teva Pharmaceuticals USA, Inc. | 8 | $128 |
| Idorsia Pharmaceuticals US Inc | 7 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $77 |
| Axsome Therapeutics, Inc. | 3 | $56 |
| Indivior Inc. | 2 | $49 |
| Lundbeck LLC | 2 | $37 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Almatica Pharma LLC | 1 | $14 |
How this compares
$3,942 in reported general payments places this provider in the 85th percentile of 443 psychiatric/mental health providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 123 | $359,853 |
| Invega TrinzaPaliperidone Palmitate | 21 | $157,960 |
| Wellbutrin XlBupropion Hcl | 12 | $70,744 |
| FanaptIloperidone | 24 | $52,433 |
| LybalviOlanzapine/Samidorphan Malate | 27 | $42,099 |
| CaplytaLumateperone Tosylate | 16 | $27,080 |
| AristadaAripiprazole Lauroxil | 13 | $22,881 |
| Clozapine | 176 | $10,112 |
| TrintellixVortioxetine Hydrobromide | 14 | $7,403 |
| Depakote ErDivalproex Sodium | 15 | $5,495 |
| Haloperidol Decanoate | 181 | $5,359 |
| Fluphenazine Hcl | 74 | $4,709 |
| Divalproex Sodium ErDivalproex Sodium | 238 | $4,179 |
| Fluphenazine Decanoate | 51 | $4,071 |
| Paliperidone ErPaliperidone | 24 | $3,409 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Invega Trinza | $864 | $517,813144 claims |
| Alkermes, Inc.Lybalvi, Aristada | $616 | $64,98140 claims |
| Vanda Pharmaceuticals Inc.Fanapt | $647 | $52,43324 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $352 | $27,08016 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $77 | $7,40314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 443 psychiatric/mental health providers in Iowa.
Other psychiatric/mental health in Des Moines
- Quentin ChambersDes Moines$40K
- Cynthia CoenenDes Moines$8K
- Rachel FilzerDes Moines$5K
- Tarrah HollidayAtlantic$421K
- Kelsie SwisherParkersburg$235K
- Jennifer BradleyCedar Rapids$66K
- Kama AusbornWaterloo$64K
- Tenaea JeppesonFort Dodge$38K
- Jennifer WittmanCoralville$25K
- Amy MorinCedar Rapids$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.